134
views
0
recommends
+1 Recommend
0 collections
    10
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Site-specific prolapse surgery. II. Vaginal paravaginal repair augmented with either synthetic mesh or remodelling xenograft

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction and hypothesis

          This study aims to answer the question, “Does tissue augmentation improve the mechanical repair of displacement cystourethrocoele?”

          Methods

          A retrospective cohort study comparing 108 bridging graft vaginal paravaginal repairs (89 tissue-inductive xenografts and 19 polypropylene mesh) to 59 native tissue historical controls was conducted. Main outcome measures were same-site prolapse recurrence and time to failure. Initial reliability was evaluated by chi-squared test, 10-year durability by Kaplan–Meier survival analysis and risk factors by Cox regression.

          Results

          Late recurrence was 17.7% lower with augmentation (logrank test χ 2 = 8.4, p value = 0.0038 < 0.05, adjusted regression analysis χ 2 = 2.94; p value = 0.0866 <0.10), implicating collagen degeneration in repair failure.

          Conclusions

          Rebuilding the pubocervical septum, from arcus to arcus and pubic ramus to pericervical ring, satisfies the mechanical but not the metabolic hernia principles. Bridging grafts simplify technical repair (reducing prolapse persistence from 10.2% to 4.6%), and also rejuvenate adjacent connective tissue (reducing late recurrence from 22.6% to 4.9%).

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Macrophage phenotype as a determinant of biologic scaffold remodeling.

          Macrophage phenotype can be characterized as proinflammatory (M1) or immunomodulatory and tissue remodeling (M2). The present study used a rat model to determine the macrophage phenotype at the site of implantation of two biologic scaffolds that were derived from porcine small intestinal submucosa (SIS) and that differed mainly according to their method of processing: the Restore device (SIS) and the CuffPatch device (carbodiimide crosslinked form of porcine-derived SIS (CDI-SIS)). An autologous tissue graft was used as a control implant. Immunohistologic methods were used to identify macrophage surface markers CD68 (pan macrophages), CD80 and CCR7 (M1 profile), and CD163 (M2 profile) during the remodeling process. All graft sites were characterized by the dense population of CD68+ mononuclear cells present during the first 4 weeks. The SIS device elicited a predominantly CD163+ response (M2 profile, p < 0.001) and showed constructive remodeling at 16 weeks. The CDI-SIS device showed a predominately CD80+ and CCR7+ response (M1 profile, p < 0.03), and at 16 weeks was characterized by chronic inflammation. The autologous tissue graft showed a predominately CD163+ response (M2) at 1 week, with a dual M1/M2 population (CD80+, CCR7+, and CD163+) by 2 and 4 weeks and moderately well organized connective tissue by 16 weeks. The processing methods used during the manufacturing of a biologic scaffold can have a profound influence upon the macrophage phenotype profile and downstream remodeling events. Routine histologic examination alone is inadequate to determine the phenotype of mononuclear cells that participate in the host response to the scaffold.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Xenogeneic extracellular matrix as a scaffold for tissue reconstruction.

            Bioscaffolds derived from xenogeneic extracellular matrix (ECM) have been used in numerous tissue engineering applications. The safety and efficacy of such scaffolds when used for the repair and reconstruction of numerous body tissues including musculoskeletal, cardiovascular, urogenital and integumentary structures has been shown in both preclinical animal studies and in human clinical studies. More than 200,000 human patients have been implanted with xenogeneic ECM scaffolds. These ECM scaffolds are typically prepared from porcine organs such as small intestine or urinary bladder, which are subjected to decellularization and terminal sterilization without significant loss of the biologic effects of the ECM. The composition of these bioscaffolds includes the structural and functional proteins that are part of native mammalian extracellular matrix. The three-dimensional organization of these molecules distinguishes ECM scaffolds from synthetic scaffold materials and is associated with constructive tissue remodeling instead of scar tissue. The biologic response to these xenogeneic bioscaffolds, including the immune response, is discussed herein. Copyright 2004 Elsevier B.V.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study.

              Biologic scaffold materials prepared from extracellular matrix are currently available for the surgical repair of damaged or missing musculotendinous tissue. These scaffolds differ in their species and tissue of origin, methods of processing, and methods of terminal sterilization. The purpose of the present study was to evaluate the host-tissue morphologic response to five commercially available extracellular matrix-derived biologic scaffolds used for orthopaedic soft-tissue repair in a rodent model. One hundred twenty-six Sprague-Dawley rats were divided into six groups of twenty-one animals each. A defect was created in the musculotendinous tissue of the abdominal wall of each animal and then was repaired with one of five different scaffold materials (GraftJacket, Restore, CuffPatch, TissueMend, Permacol) or with the excised autologous tissue. Three animals from each group were killed at one of seven time-points after surgery (two, four, seven, fourteen, twenty-eight, fifty-six, and 112 days), and the specimens were examined with histologic and morphologic methods. The degree of cellular infiltration, multinucleated giant cell presence, vascularity, and organization of the replacement connective tissue were evaluated with semiquantitative methods. Each device elicited a distinct morphologic response that differed with respect to cellularity (p<0.001), vascularity (p<0.01), the presence of multinucleated giant cells (p<0.01), and organization of the remodeled tissue (p<0.01) at or after the Day 7 time-point. More rapidly degraded devices such as Restore and autologous tissue showed the greatest amount of cellular infiltration, especially at the early time-points. Devices that degraded slowly, such as CuffPatch, TissueMend, and Permacol, were associated with the presence of foreign-body giant cells, chronic inflammation, and/or the accumulation of dense, poorly organized fibrous tissue. Biologic scaffold materials composed of extracellular matrix elicit distinct host-tissue histologic and morphologic responses, depending on species of origin, tissue of origin, processing methods, and/or method of terminal sterilization.
                Bookmark

                Author and article information

                Contributors
                +61-2-93278033 , +61-2-93273403 , richard_reid@dbgyn.com
                Journal
                Int Urogynecol J
                International Urogynecology Journal
                Springer-Verlag (London )
                0937-3462
                1433-3023
                11 January 2011
                11 January 2011
                May 2011
                : 22
                : 5
                : 601-609
                Affiliations
                [1 ]School of Rural Medicine, Armidale, Australia
                [2 ]Statistics Department, Macquarie University, Sydney, Australia
                [3 ]Specialist Medical Centre, Suite #4, 235 New South Head Rd, Edgecliff, Sydney, NSW 2027 Australia
                Article
                1346
                10.1007/s00192-010-1346-3
                3072475
                21222113
                f2ffc2d6-a03c-4653-a709-53843aa7f066
                © The Author(s) 2011
                History
                : 22 April 2009
                : 27 October 2010
                Categories
                Original Article
                Custom metadata
                © The International Urogynecological Association 2011

                Obstetrics & Gynecology
                tissue engineering bioprosthesis,reconstructive surgical procedures/pelvis/methods,vaginal paravaginal repair/treatment outcome,connective tissue pathology,hernia/therapy,cystocoele aetiology

                Comments

                Comment on this article